Footy, they spent the time and money on Andash because it is an excellent project and because it was their only asset.
Now the have other very valuable assets only recently acquired, with more exploration potential and no permitting issues.
Why is anyone wondering why the shift in focus while they wait for Andash permits?
- Forums
- ASX - By Stock
- KGL
- results released
results released, page-23
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.56M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $18.23K | 173.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 595332 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 36376 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 595332 | 0.100 |
1 | 89600 | 0.095 |
1 | 7789 | 0.091 |
2 | 111125 | 0.090 |
1 | 6000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 36376 | 2 |
0.110 | 74758 | 3 |
0.115 | 40497 | 1 |
0.120 | 242648 | 1 |
0.130 | 33 | 1 |
Last trade - 11.29am 16/07/2024 (20 minute delay) ? |
Featured News
KGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online